Latest Breaking News On - Dai fukumura - Page 1 : comparemela.com

 E-Mail BOSTON - It s a real-life plot worthy of a classic spy novel: Researchers at Massachusetts General Hospital (MGH), the Dana-Farber Cancer Institute and other Boston-area research centers are turning the tables on glioblastomas, the most devastating and aggressive form of brain cancer, by transforming a type of cell that normally protects tumors and inhibits effective drug therapy into a stone-cold glioblastoma killer. Glioblastoma, a type of brain tumor, is rapidly fatal: Most patients die within two years of diagnosis despite aggressive therapies such as brain surgery, whole-brain radiation and chemotherapy. Despite hopes that a class of drugs known as immune checkpoint blockers (ICBs) - drugs that have revolutionized the treatment of patients with malignant melanoma, non-small-cell lung cancer, and other solid tumors - could also benefit patients with glioblastoma, ICBs have not been effective against the disease in clinical trials to date.

United statesDana farber cancer instituteEdwinl steeleRakeshk jainHye jung kimZohreh amoozgarDai fukumuraNature communicationsJane trust foundationNational institutes of healthHarvard medical schoolNational foundation for cancer researchResearch instituteHarvard ludwig cancer centerDepartment of radiation oncologyResearch foundation